To investigate the clinical manifestations of Aspergillus infections i
n lung transplant recipients, we reviewed the mycology and autopsy rep
orts of all double (DLT=93) and single (SLT=48) lung transplant recipi
ents from November 1983 to May 1993. Positive Aspergillus cultures wer
e identified in 22% of the recipients (DLT=21, SLT=10). Colonization a
lone was present in 19 recipients (DLT=16, SLT=3). Complicated Aspergi
llus infection included Aspergillus bronchitis (DLT=1, SLT=1), aspergi
lloma (SLT=2), pulmonary invasive aspergillosis (DLT=1, SLT=2), dissem
inated aspergillosis (DLT=1, SLT=2), empyema (DLT=1), and a retroperit
oneal abscess (DLT=1). Symptoms were seen only in patients with compli
cated lung infections and CXR abnormalities began in the native lung o
f four SLT recipients. Twenty patients survived (DLT=17, SLT=3) and 11
died (DLT=4, SLT=7) of disseminated aspergillosis (SLT=2), pulmonary
invasive disease (DLT=1), bronchiolitis obliterans (DLT=2, SLT=2, CMV
pneumonitis (SLT=1), diffuse alveolar damage (SLT=2), and hyperacute r
ejection (DLT=1). Complicated infection and mortality were more common
in SLTs than DLTs (P<0.05). We conclude that infection with Aspergill
us is not infrequent in the lung transplantation population. Single lu
ng recipients develop more complicated in infection than double lung r
ecipients after Aspergillus infection, with native lung being a potent
ial source of infection.